Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology

SAN JOSE, Calif.: SAN JOSE, Calif., Oct. 6, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the China National Intellectual Property Administration (CNIPA) has issued a Notification of Grant of Patent Right...

Click to view original post